Fellowship · Madison, WI
Sponsored by University of Wisconsin Hospitals and Clinics
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature · 2022 · 697 citations · Rebecca Richards
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.
Nature · 2025 · 172 citations · Rebecca Richards
Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 76 citations · Margo Hoover-Regan
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.
Journal for immunotherapy of cancer · 2024 · 140 citations · Christian Capitini
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 146 citations · Cathy Lee-Miller
Tumor inflammation-associated neurotoxicity.
Nature medicine · 2023 · 143 citations · Rebecca Richards
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2021 · 184 citations · Paul Sondel
Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment.
Nature communications · 2022 · 155 citations · Paul Sondel